ESR1 and endometrioid adenocarcinoma: A small percentage of prototypical endometrial clear cell carcinomas are ER-positive, and clear cell change in endometrioid carcinoma may be accompanied by significant diminution of ER and PR expression 52; therefore ER and PR should always be used in conjunction with a panel of other markers 57.